Literature DB >> 12874787

HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies.

Karen L Gross1, David M Neskey, Nitasha Manchanda, Stanislawa Weremowicz, Michael S Kleinman, Romana A Nowak, Azra H Ligon, Piere Rogalla, Klaus Drechsler, Jörn Bullerdiek, Cynthia C Morton.   

Abstract

The high mobility group gene, HMGA2, is frequently expressed in uterine leiomyomata (UL) with chromosomal rearrangements of 12q15. In contrast, HMGA2 expression has not been detected in karyotypically normal UL or in myometrium, but has been detected in these tissues after culture. To characterize further the expression pattern of HMGA2, we assessed HMGA2 expression by RT-PCR followed by Southern blot hybridization, and by real-time PCR in three tissue panels: (1) primary myometrial cultures, (2) uncultured tissue from 15 karyotypically normal samples consisting of eleven 46,XX UL and four matched myometrial specimens, and (3) uncultured tissue from ten UL with 12q15 rearrangements and three matched myometrial specimens. HMGA2 expression was detected in all samples from the three panels. The level of HMGA2 expression in karyotypically normal UL was similar to the level of expression in myometrium; however, it was significantly less than the level measured in UL with 12q15 rearrangements. This expression analysis by use of detection methods of different sensitivities underscores the importance of studies of HMGA2 expression in uncultured tissues and of careful interpretation of results from experiments on cultured cells. Moreover, detection of HMGA2 expression in myometrium and in UL without 12q15 rearrangements, tissues previously thought not to express HMGA2, suggests that HMGA2 expression is required in normal adult myometrial physiology. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874787     DOI: 10.1002/gcc.10240

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  23 in total

1.  Disseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma.

Authors:  Zehra Ordulu; Paola Dal Cin; Wilson W S Chong; Kwong Wai Choy; Charles Lee; Michael G Muto; Bradley J Quade; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

2.  Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.

Authors:  Jennelle C Hodge; Tae-Min Kim; Jonathan M Dreyfuss; Priya Somasundaram; Nicole C Christacos; Marissa Rousselle; Bradley J Quade; Peter J Park; Elizabeth A Stewart; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

Review 3.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

4.  Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata.

Authors:  Mark A Hayden; Zehra Ordulu; C Scott Gallagher; Bradley J Quade; Raymond M Anchan; Nia Robinson Middleton; Serene S Srouji; Elizabeth A Stewart; Cynthia C Morton
Journal:  Cancer Genet       Date:  2018-02-19

5.  Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.

Authors:  Sunil K Halder; Archana Laknaur; Jessica Miller; Lawrence C Layman; Michael Diamond; Ayman Al-Hendy
Journal:  Mol Genet Genomics       Date:  2014-10-18       Impact factor: 3.291

6.  MED12 exon 2 mutations in histopathological uterine leiomyoma variants.

Authors:  Netta Mäkinen; Pia Vahteristo; Kati Kämpjärvi; Johanna Arola; Ralf Bützow; Lauri A Aaltonen
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

7.  Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.

Authors:  Jennelle C Hodge; Bradley J Quade; Mark A Rubin; Elizabeth A Stewart; Paola Dal Cin; Cynthia C Morton
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

8.  Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele.

Authors:  Jennelle C Hodge; Karen T Cuenco; Karen L Huyck; Priya Somasundaram; Carolien I M Panhuysen; Elizabeth A Stewart; Cynthia C Morton
Journal:  Hum Genet       Date:  2009-01-09       Impact factor: 4.132

9.  The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells.

Authors:  Meagan M Grudzien; Philip Steven Low; Peter C Manning; Melissa Arredondo; Robert J Belton; Romana A Nowak
Journal:  Fertil Steril       Date:  2009-01-09       Impact factor: 7.329

10.  HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma.

Authors:  Yinuo Li; Wenan Qiang; Brannan Brooks Griffin; Tingting Gao; Debabrata Chakravarti; Serdar Bulun; J Julie Kim; Jian-Jun Wei
Journal:  Fertil Steril       Date:  2020-08-28       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.